JAK and STAT proteins in cellular signal transduction;Proteines JAK et STAT dans la transmission du signal cellulaire

Medecine/Sciences

Volumn 13, Issue 11, 1997, Pages 1277-1284

  Vignais, Marie Luce ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TYROSINE;

CELL NUCLEUS; CELL PROLIFERATION; DIMERIZATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; LEUKEMIA; LIGAND BINDING; PLEIOTROPY; PROTEIN DNA BINDING; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

JANUS;

EID: 0030708881     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/546     Document Type: Review

References (32)

1. Kahn A. De la membrane au noyau, un couplage direct entre les récepteurs de cytokines et la machinerie transcriptionnelle. Med Sci 1994; 10: 202-5.
2. Briscoe J, Kohlhuber F, Müller M. JAKs and STATs branch out. Trends Cell Bial 1996; 6: 336-40.
3. Watanabe S, Arai KI. Roles of the JAK-STAT system in signal transduction via cytokine receptors. Curr Opin Genet Dev 1996; 6: 587-96.
4. Winston LA, Hunter T. Intracellular signalling: putting JAKs on the kinase MAP. Curr Biol 1996; 6: 668-71.
5. O'Shea JJ. Jaks, Stats, cytokine signal transduction and immunoregulation: are we there yet? Immunity 1997; 7: 1-11.
6. Darnell J Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-21.
7. Guschin D, Rogers N, Briscoe J, Witthuhn B, Watling D, Horn F, Pellegrini S, Yasukawa K, Heinrich P, Stark GR, Ihle JN. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J 1995; 14: 1421-9.
8. Han Y, Leaman DW, Watling D, Rogers NC, Groner B, Kerr IM, Wood WI, Stark GR. Participation of JAK and STAT proteins in growth hormone-induced signaling. J Biol Chem 1996; 271: 5947-52.
9. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE, Stark GR. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 1996; 16: 369-75.
10. Vignais ML, Sadowski HB, Watling D, Rogers NC, Gilman MZ. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol 1996; 16: 1759-69.
11. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 241-50.
12. Beadling C, Ng J, Babbage JW, Cantrell DA. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J 1996; 15: 1902-13.
13. Gerhartz C, Heesel B, Sasse I, Hemmann U, Landgraf C, Schneider-Mergener J, Horn F, Heinrich PC, Graeve L. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp 130. J Biol Chem 1996; 271: 12991-8.
14. Vinkemeier U, Cohen SL, Moarefi I, Chait BT, Kuriyan J, Darnell JE Jr. DNA binding of in vivo activated Stat1α, STAT1β and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J 1996; 15: 5616-26.
15. Stöcklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996; 383: 726-8.
16. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 1996; 383: 344-7.
17. Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 1996; 15: 4928-39.
18. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Statl gene results in compromised innate immunity to viral disease. Cell 1996; 84: 443-50.
19. Meraz MA, White JM, Sheehan KCF, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, Dubois RN, Clark R, Aguet M, Schreiber RD. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84: 431-42.
20. Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S. STAT3 activation is a critical step in gp130-medialed terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci USA 1996; 93: 3963-6.
21. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996; 382: 174-7.
22. Thierfelder WE, van Deursen J, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DAA, Doherty PC, Grosveld G, Ihle JN. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996; 382: 171-4.
23. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996; 4: 313-9.
24. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DAA, Doherty PC, Grosveld G, Paul WE, Ihle JN. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630-3.
25. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura SI, Nakanishi K, Yoshida N, Kishimoto T, Akira S. Essential role of Stat6 in IL-4 signalling. Nature 1996; 380: 627-30.
26. Klingmüller U, Lorentz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995; 80: 729-38.
27. Kim TK, Maniatis T. Regulation of interferon-γ-activated STAT1 by the ubiquitin-proteasome pathway. Science 1996; 273: 1717-9.
28. Macchi M, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarangelo LD. Mutation of Jak-3 gene in patients with autosomal severe combined deficiency (SCID). Nature 1995; 377: 65-8.
29. Russel SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Javad Aman M, Migone TS, Noguchi M, Markert ML, Buckley RH, O'Shea JJ, Leonard WJ. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995; 270: 797-800.
30. Migone TS, J-X L, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 1995; 269: 79-81.
31. Zong C, Yan R, August A, Darnell JE Jr. Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J 1996; 15: 4515-25.
32. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267: 1782-8.